Clinical trials
Observational Multiple Sclerosis trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 12 |
| Unknown status | 5 |
| Active, not recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Basel, Switzerland | 11 |
| Biogen | 8 |
| Novartis Pharmaceuticals | 8 |
| Insel Gruppe AG, University Hospital Bern | 5 |
| Klinik Valens | 3 |
| Bayer | 2 |
| Cantonal Hospital of St. Gallen | 2 |
| Claudio Gobbi | 2 |
| University of Zurich | 2 |
| Ente Ospedaliero Cantonale, Bellinzona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 56 |
| Fatigue | 7 |
| Cognitive Dysfunction | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Agammaglobulinemia | 1 |
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.